Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
ValiScreen Human Adenosine A2B Cell Line
ValiScreen Human Adenosine A2B Cell Line
GPCR Receptor Cells and Membranes
| Feature | Specification |
|---|---|
| Application |
cAMP Drug Discovery & Development |
| G-Alpha Natural Receptor | Gs |
| Special Ordering Information | Requires accepted Terms and Conditions. Additional agreement needed for commercial use. |
| Validation |
Binding cAMP |
Product variant
Unit Size: 5 million
Part #:
ES-013-C
For research use only. Not for use in diagnostic procedures. Cell Line Terms and Conditions must be accepted before orders are placed. Additional agreement needed for commercial use. Click here.
ValiScreen Human Adenosine A2B Cell Line
GPCR Receptor Cells and Membranes
ValiScreen Human Adenosine A2B Cell Line
Product information
Overview
Revvity's ValiScreen cell lines are provided in two vials of frozen cells, each containing ~2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line.
Clonal selection Revvity's ValiScreen cell lines is carried out with receptor binding. High and low expressors are n tested and selected optimal binding and functional response according to receptor specific transduction pathway.
Revvity’s ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Please use link above to accept Terms and Conditions or to request an agreement for commercial use.
Specifications
| Application |
cAMP
Drug Discovery & Development
|
|---|---|
| Brand |
ValiScreen
|
| G-Alpha Natural Receptor |
Gs
|
| Host Cell Line |
HEK293
|
| Host Species |
Human
|
| One Unit Contains |
2 vial(s)
|
| Product Group |
Cell Line
|
| Receptor |
Adenosine
|
| Second Messenger Release |
cAMP
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Special Ordering Information |
Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
|
| Target Class |
GPCR
|
| Therapeutic Area |
Cardiovascular
Central Nervous System
Inflammation
Metabolic
|
| Unit Size |
5 million
|
| Validation |
Binding
cAMP
|
Resources
Are you looking for resources, click on the resource type to explore further.
Brochure
Radioligand selection guide
Discover a comprehensive collection of GPCR cell lines, membrane preparations, and complementary radioligands designed to drive...
Loading...
How can we help you?
We are here to answer your questions.
